Characteristics of Patients With COVID-19 in Meta State, Colombia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study aims to collect detailed clinical information on confirmed or suspected patients of COVID-19 treated in hospitals from Meta State, Colombia. The objectives are:

1. To establish the characteristics of patients and healthcare workers treated with COVID-19.
2. To assess previous predisposing morbidity.
3. To detail clinical factors associated with complications.
4. To profile clinical indicators for severity and outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia

NCT04887246

Covid19 SARS-CoV2 Infection

COMPLETED

Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine

NCT04654416

Covid-19

COMPLETED

COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador

NCT04362969

COVID

UNKNOWN

Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19

NCT04505709

Covid19

UNKNOWN

Study of COVID-19 Prognostic Factors in Hospitalized Patients

NCT05102708

COVID-19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hospital database and clinical charts in an electronic format of patients with suspected or confirmed COVID-19 will be reviewed to include in the study. Multiple centers from the eastern Colombian prairies caring for this population will participate to provide an understanding of the behavior of the epidemic and accurate clinical comprehension of the disease. Healthcare centers involved in providing an evaluation of patients infected with SARS-CoV-2 will be invited to participate.

The study will focus on the routine or new treatment strategies provided and a large population of patients analyzed would be desirable. It will allow identifying the most relevant factors associated with clinical outcomes, complications, and prognosis, with an appropriate statistical methodology for the analysis of observational nature.

Variables of individuals assisted will be recorded as well as the end results, such as baseline characteristics of individuals and disease, and main outcomes such as mortality, need for ICU attention, mechanical ventilation, and length of stay.

These results will be used to promote an improvement in the quality of care and individual and cluster decisions in the region.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID SARS-CoV 2 SARS Pneumonia SARS (Disease) SARS (Severe Acute Respiratory Syndrome)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients treated with COVID-19

All populations of patients admitted with COVID-19 in healthcare institutions involved. No intervention but standard care designed by national guidelines will be provided.

No interventions assigned to this group